María Vila-Casadesús

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Elena Vila-Navarro · 3 shared papers, 2018–2021 · strength 0.34
   • Paper MicroRNAs Deregulated in Intraductal Papillary Mucinous Neoplasm Converge on Actin Cytoskeleton-Related Pathways That A… DOI 10.3390/cancers13102369↗
   • Paper MiR-93 is related to poor prognosis in pancreatic cancer and promotes tumor progression by targeting microtubule dynami… DOI 10.1038/s41389-020-0227-y↗
   • Paper Deciphering microRNA targets in pancreatic cancer using miRComb R package. DOI 10.18632/oncotarget.24034↗
2. Meritxell Gironella · 3 shared papers, 2018–2021 · strength 0.34
   • Paper MicroRNAs Deregulated in Intraductal Papillary Mucinous Neoplasm Converge on Actin Cytoskeleton-Related Pathways That A… DOI 10.3390/cancers13102369↗
   • Paper MiR-93 is related to poor prognosis in pancreatic cancer and promotes tumor progression by targeting microtubule dynami… DOI 10.1038/s41389-020-0227-y↗
   • Paper Deciphering microRNA targets in pancreatic cancer using miRComb R package. DOI 10.18632/oncotarget.24034↗
3. Elena Fernández-Castañer · 2 shared papers, 2020–2021 · strength 0.25
   • Paper MicroRNAs Deregulated in Intraductal Papillary Mucinous Neoplasm Converge on Actin Cytoskeleton-Related Pathways That A… DOI 10.3390/cancers13102369↗
   • Paper MiR-93 is related to poor prognosis in pancreatic cancer and promotes tumor progression by targeting microtubule dynami… DOI 10.1038/s41389-020-0227-y↗
4. Cristina Fillat · 2 shared papers, 2018–2020 · strength 0.20
   • Paper MiR-93 is related to poor prognosis in pancreatic cancer and promotes tumor progression by targeting microtubule dynami… DOI 10.1038/s41389-020-0227-y↗
   • Paper Deciphering microRNA targets in pancreatic cancer using miRComb R package. DOI 10.18632/oncotarget.24034↗
5. Giulia Raimondi · 2 shared papers, 2018–2020 · strength 0.20
   • Paper MiR-93 is related to poor prognosis in pancreatic cancer and promotes tumor progression by targeting microtubule dynami… DOI 10.1038/s41389-020-0227-y↗
   • Paper Deciphering microRNA targets in pancreatic cancer using miRComb R package. DOI 10.18632/oncotarget.24034↗
6. Alberto Hernando‐Calvo · 1 shared paper, 2024 · strength 0.16
   • Paper A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Prof… DOI 10.1016/j.clcc.2024.05.002↗
7. Aaron Richard Hansen · 1 shared paper, 2024 · strength 0.16
   • Paper A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Prof… DOI 10.1016/j.clcc.2024.05.002↗
8. Benjamin Haibe‐Kains · 1 shared paper, 2024 · strength 0.16
   • Paper A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Prof… DOI 10.1016/j.clcc.2024.05.002↗
9. Ana P. Vivancos · 1 shared paper, 2024 · strength 0.16
   • Paper A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Prof… DOI 10.1016/j.clcc.2024.05.002↗
10. Lillian Siu · 1 shared paper, 2024 · strength 0.16
    • Paper A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Prof… DOI 10.1016/j.clcc.2024.05.002↗
11. Philippe Lucien Bedard · 1 shared paper, 2024 · strength 0.16
    • Paper A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Prof… DOI 10.1016/j.clcc.2024.05.002↗
12. Maria Rovira-Rigau · 1 shared paper, 2020 · strength 0.11
    • Paper MiR-93 is related to poor prognosis in pancreatic cancer and promotes tumor progression by targeting microtubule dynami… DOI 10.1038/s41389-020-0227-y↗
13. Philippe Soubeyran · 1 shared paper, 2020 · strength 0.11
    • Paper MiR-93 is related to poor prognosis in pancreatic cancer and promotes tumor progression by targeting microtubule dynami… DOI 10.1038/s41389-020-0227-y↗
14. Juan Iovanna · 1 shared paper, 2020 · strength 0.11
    • Paper MiR-93 is related to poor prognosis in pancreatic cancer and promotes tumor progression by targeting microtubule dynami… DOI 10.1038/s41389-020-0227-y↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.